Beneficial effect of intravenous cyclophosphamide and oral prednisone on D-penicillamine-associated bronchiolitis obliterans.
D000284:Administration, Oral; D000328:Adult; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001991:Bronchitis / Q000139:chemically induced / Q000188:drug therapy*; D003251:Constriction, Pathologic / Q000139:chemically induced / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D010396:Penicillamine / Q000009:adverse effects*; D011241:Prednisone / Q000627:therapeutic use*
D003520:Cyclophosphamide; D010396:Penicillamine; D011241:Prednisone